Discovering European Penny Stocks: Hyloris Pharmaceuticals And 2 Other Noteworthy Picks

European markets have recently experienced volatility, influenced by Middle East tensions, a hawkish European Central Bank stance, and mixed economic indicators across the eurozone. Amidst these fluctuations, investors often look to penny stocks as a potential avenue for growth. While the term "penny stocks" may seem outdated, it still signifies opportunities in smaller or newer companies that can offer significant value when backed by strong financials and sound fundamentals.

Let's dive into some prime choices out of the screener.

Hyloris Pharmaceuticals (ENXTBR:HYL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Hyloris Pharmaceuticals SA is a specialty pharmaceutical company operating in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific with a market cap of €117.60 million.

Operations: Hyloris generates revenue from its Pharmaceuticals segment, amounting to €9.83 million.

Market Cap: €117.6M

Hyloris Pharmaceuticals, with a market cap of €117.60 million, has shown revenue growth in its Pharmaceuticals segment, reaching €9.83 million. Despite being unprofitable with a negative return on equity of -18.66%, the company has reduced its net loss over five years at 13.1% annually and improved sales from €3.02 million to €4.7 million year-over-year for the half-year ending June 2026. Hyloris maintains more cash than debt and covers both short-term and long-term liabilities with assets, though it faces less than a year of cash runway if current free cash flow trends persist.

• Click to explore a detailed breakdown of our findings in Hyloris Pharmaceuticals' financial health report.
• Gain insights into Hyloris Pharmaceuticals' future direction by reviewing our growth report.

Xilam Animation (ENXTPA:ALXIL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Xilam Animation is an integrated animation studio that creates, produces, and distributes original programs for children and adults across France, Europe, the Americas, and Asia-East-Africa with a market cap of €24.48 million.

Operations: The company generates revenue primarily from the production of audiovisual works and related products, amounting to €16.09 million.

Market Cap: €24.48M

Xilam Animation, with a market cap of €24.48 million, reported half-year revenues of €7.75 million, up from €6.05 million the previous year, though it remains unprofitable with a net loss of €0.996 million. The company has experienced significant executive restructuring, appointing Caterina Gonnelli-Linden as Co-CEO and promoting Camille Wiplier and Safaa Benazzouz to Deputy CEOs to enhance operational efficiency and content distribution strategies globally. Despite its volatility and high debt levels relative to short-term liabilities (€35.3M), Xilam's operating cash flow adequately covers its debt obligations, supporting strategic growth initiatives in animation production and distribution.

• Get an in-depth perspective on Xilam Animation's performance by reading our balance sheet health report here.
• Learn about Xilam Animation's future growth trajectory here.

Anora Group Oyj (HLSE:ANORA)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Anora Group Oyj is involved in the production, import, sale, and distribution of alcoholic and non-alcoholic beverages across Finland, Sweden, Norway, Denmark, and internationally with a market cap of €256.37 million.

Operations: The company's revenue is derived from three main segments: Wine (€286.8 million), Spirits (€211.4 million), and Industrial (€230.1 million).

Market Cap: €256.37M

Anora Group Oyj, with a market cap of €256.37 million, has secured a strategic distribution agreement with Bacardi in Sweden and Norway, potentially boosting annual net sales by €25-30 million. Despite this positive development, Anora faces challenges such as low return on equity (1.1%) and declining earnings over the past five years. The company's debt is well covered by operating cash flow (36.7%), and short-term assets exceed both short-term and long-term liabilities, indicating sound liquidity management. However, profit margins have decreased to 0.6%, reflecting ongoing profitability pressures amidst volatile earnings growth forecasts of 36.8% annually.

• Click here to discover the nuances of Anora Group Oyj with our detailed analytical financial health report.
• Examine Anora Group Oyj's earnings growth report to understand how analysts expect it to perform.

Taking Advantage

• Access the full spectrum of 265 European Penny Stocks by clicking on this link.
• Interested In Other Possibilities? AI is about to change healthcare. These 126 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com